Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Melki

Showing results (31-40 of 101) with videos related to

Pageof 11
Sort By:
Developmental Medicine and Child Neurology|June 22, 2021
Opsoclonus-myoclonus in Aicardi-Goutières syndromeSalam Alburaiky, Russell C Dale, Yanick J Crow, et al.
Pediatric Rheumatology Online Journal|April 4, 2018
Clinical features of children with enthesitis-related juvenile idiopathic arthritis / juvenile spondyloarthritis followed in a French tertiary care pediatric rheumatology centreMaxime Goirand, Sylvain Breton, Frédéric Chevallier, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 6, 2019
Circulating Interferon-α Measured With a Highly Sensitive Assay as a Biomarker for Juvenile Inflammatory Myositis Activity: Comment on the Article by Mathian et alIsabelle Melki, Hervé Devilliers, Cyril Gitiaux, et al.
Eclinicalmedicine|July 24, 2023
Calculating the fraction of Kawasaki disease potentially attributable to seasonal pathogens: a time series analysisZaba Valtuille, Alain Lefevre-Utile, Naim Ouldali, et al.
RMD Open|June 15, 2023
Assessment of type I interferon response in routine practice in France in 2022Anais Nombel, Anne Perrine Foray, Lorna Garnier, et al.
EJNMMI Research|April 2, 2024
Brain 18 F-FDG PET reveals cortico-subcortical hypermetabolic dysfunction in juvenile neuropsychiatric systemic lupus erythematosusSebastian Rodrigo, Stefania Costi, Pierre Ellul, et al.
Clinical Immunology (Orlando, Fla.)|May 9, 2024
Proteomic mapping identifies serum marker signatures associated with MIS-C specific hyperinflammation and cardiovascular manifestationAndrea Reiter, Emely L Verweyen, Emmanuelle Queste, et al.
RMD Open|September 16, 2022
Outcome of COVID-19 in patients with rheumatic and inflammatory diseases treated with mycophenolic acid: data from the French RMD COVID-19 cohortMarie-Elise Truchetet, Elodie Drumez, Thomas Barnetche, et al.
The Journal of Rheumatology|December 3, 2013
Effect of biologic treatments on growth in children with juvenile idiopathic arthritisFlorence Uettwiller, Julie Perlbarg, Graziella Pinto, et al.
Rheumatology (Oxford, England)|January 2, 2023
Osteonecrosis in patients with juvenile dermatomyositis: is it associated with anti-MDA5 autoantibody?Brigitte Bader-Meunier, Sylvain Breton, Darragh Duffy, et al.
Pageof 11

Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
Developmental Medicine and Child Neurology|June 22, 2021
Opsoclonus-myoclonus in Aicardi-Goutières syndromeSalam Alburaiky, Russell C Dale, Yanick J Crow, et al.
Pediatric Rheumatology Online Journal|April 4, 2018
Clinical features of children with enthesitis-related juvenile idiopathic arthritis / juvenile spondyloarthritis followed in a French tertiary care pediatric rheumatology centreMaxime Goirand, Sylvain Breton, Frédéric Chevallier, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 6, 2019
Circulating Interferon-α Measured With a Highly Sensitive Assay as a Biomarker for Juvenile Inflammatory Myositis Activity: Comment on the Article by Mathian et alIsabelle Melki, Hervé Devilliers, Cyril Gitiaux, et al.
Eclinicalmedicine|July 24, 2023
Calculating the fraction of Kawasaki disease potentially attributable to seasonal pathogens: a time series analysisZaba Valtuille, Alain Lefevre-Utile, Naim Ouldali, et al.
RMD Open|June 15, 2023
Assessment of type I interferon response in routine practice in France in 2022Anais Nombel, Anne Perrine Foray, Lorna Garnier, et al.
EJNMMI Research|April 2, 2024
Brain 18 F-FDG PET reveals cortico-subcortical hypermetabolic dysfunction in juvenile neuropsychiatric systemic lupus erythematosusSebastian Rodrigo, Stefania Costi, Pierre Ellul, et al.
Clinical Immunology (Orlando, Fla.)|May 9, 2024
Proteomic mapping identifies serum marker signatures associated with MIS-C specific hyperinflammation and cardiovascular manifestationAndrea Reiter, Emely L Verweyen, Emmanuelle Queste, et al.
RMD Open|September 16, 2022
Outcome of COVID-19 in patients with rheumatic and inflammatory diseases treated with mycophenolic acid: data from the French RMD COVID-19 cohortMarie-Elise Truchetet, Elodie Drumez, Thomas Barnetche, et al.
The Journal of Rheumatology|December 3, 2013
Effect of biologic treatments on growth in children with juvenile idiopathic arthritisFlorence Uettwiller, Julie Perlbarg, Graziella Pinto, et al.
Rheumatology (Oxford, England)|January 2, 2023
Osteonecrosis in patients with juvenile dermatomyositis: is it associated with anti-MDA5 autoantibody?Brigitte Bader-Meunier, Sylvain Breton, Darragh Duffy, et al.
Pageof 11